TAM
BMY icon

Telluride Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Telluride Asset Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-5,715
Closed -$297K – 263
2014
Q1 		$297K Buy
+5,715
New +$304K 0.25% 134

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Telluride Asset Management's BMY Position: Q2 2014 in Review

Telluride Asset Management sold out of Bristol-Myers Squibb (BMY) in Q2 2014, closing a stake of 5,715 shares — an estimated $297K sold.

Telluride Asset Management first reported a position in BMY in Q1 2014 and held it in 1 quarter. The position peaked at $297K in Q1 2014. 1,303 funds tracked by Wall St. Rank hold BMY as of Q2 2014.

  • Telluride Asset Management reported no remaining Bristol-Myers Squibb position as of Q2 2014 after selling out during the quarter.
  • Telluride Asset Management sold 5,715 Bristol-Myers Squibb shares in Q2 2014, an estimated $297K.
  • Telluride Asset Management first reported a position in Bristol-Myers Squibb in Q1 2014 and held it in 1 quarter.
  • Telluride Asset Management's Bristol-Myers Squibb position peaked at $297K in Q1 2014.
  • 1,303 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2014.

Based on Telluride Asset Management's 13F filing for Q2 2014, filed 14 Aug 2014.